or Try an Advanced Search...

    Technical Analysis for PHIO - Phio Pharmaceuticals Corp.

    Grade Last Price % Change Price Change
    F 0.80 9.02% 0.07
    PHIO closed up 9.02 percent on Wednesday, May 15, 2024, on 28 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical PHIO trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    MACD Bearish Signal Line Cross Bearish 9.02%
    Crossed Above 20 DMA Bullish 9.02%
    Stochastic Reached Oversold Weakness 9.02%
    Wide Bands Range Expansion 9.02%
    Oversold Stochastic Weakness 9.02%
    Hammer Candlestick Bullish 15.57%
    Older End-of-Day Signals for PHIO ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance about 24 hours ago
    10 DMA Resistance about 24 hours ago
    Rose Above Previous Day's High about 24 hours ago
    Up 5% about 24 hours ago
    Up 3% about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PHIO Chart by TradingView
    Basic chart:

    Profile

    RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology

    Is PHIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
    May 10 Phio Pharmaceuticals GAAP EPS of -$0.47
    May 9 Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
    Apr 30 Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
    Apr 22 Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
    Apr 16 Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
    Apr 11 Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
    Apr 3 National Spotlight Features Phio’s Innovative RNAi Technology Platform
    Apr 2 Phio Pharmaceuticals GAAP EPS of -$5.20
    Apr 2 Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
    See more PHIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.85
    52 Week Low 0.5
    Average Volume 377,175
    200-Day Moving Average 1.16
    50-Day Moving Average 0.78
    20-Day Moving Average 0.74
    10-Day Moving Average 0.78
    Average True Range 0.08
    RSI (14) 54.95
    ADX 37.45
    +DI 34.71
    -DI 17.32
    Chandelier Exit (Long, 3 ATRs) 0.81
    Chandelier Exit (Short, 3 ATRs) 0.85
    Upper Bollinger Bands 0.88
    Lower Bollinger Band 0.60
    Percent B (%b) 0.72
    BandWidth 37.06
    MACD Line 0.01
    MACD Signal Line 0.00
    MACD Histogram 0.0024
    Fundamentals Value
    Market Cap 3.66 Million
    Num Shares 4.57 Million
    EPS -7.43
    Price-to-Earnings (P/E) Ratio -0.11
    Price-to-Sales 48.01
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.90
    Resistance 3 (R3) 0.89 0.84 0.88
    Resistance 2 (R2) 0.84 0.82 0.85 0.88
    Resistance 1 (R1) 0.82 0.80 0.83 0.83 0.87
    Pivot Point 0.78 0.78 0.78 0.78 0.78
    Support 1 (S1) 0.76 0.75 0.77 0.77 0.73
    Support 2 (S2) 0.71 0.74 0.72 0.72
    Support 3 (S3) 0.69 0.71 0.72
    Support 4 (S4) 0.70